Gen InCode: Paul Foulger

Gen InCode, an Oxford, UK-based company specializing in AI-powered genetic risk assessment for cardiovascular disease, has appointed Paul Foulger as CFO. Foulger previously served as group finance director at EKF Diagnostics, and is currently a non-executive director of Arcis Biotechnology and Autoclenz. He has also previously served as finance director at NovaBiotics, Elsevier Science, Venn Life Sciences, and PredictImmune, among other companies.